Home > Research > Publications & Outputs > Possible mechanisms and biomarkers of resistanc...

Electronic data

  • N_O_D_21_00593_R1

    Rights statement: This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Neuro-Oncology following peer review. The definitive publisher-authenticated version Rafael Roesler, Caroline Brunetto de Farias, André T Brunetto, Lauro Gregianin, Mariane Jaeger, Carolina Nör, Amanda Thomaz, Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma, Neuro-Oncology, 2022 24: 1210-1211, is available online at https://doi.org/10.1093/neuonc/noac061

    Accepted author manuscript, 1.27 MB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma. / Roesler, Rafael; de Farias, Caroline Brunetto; Brunetto, André T et al.
In: Neuro-Oncology, Vol. 24, No. 7, 31.07.2022, p. 1210–1211.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Roesler, R, de Farias, CB, Brunetto, AT, Gregianin, L, Jaeger, M, Nör, C & Thomaz, A 2022, 'Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma', Neuro-Oncology, vol. 24, no. 7, pp. 1210–1211. https://doi.org/10.1093/neuonc/noac061

APA

Roesler, R., de Farias, C. B., Brunetto, A. T., Gregianin, L., Jaeger, M., Nör, C., & Thomaz, A. (2022). Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma. Neuro-Oncology, 24(7), 1210–1211. https://doi.org/10.1093/neuonc/noac061

Vancouver

Roesler R, de Farias CB, Brunetto AT, Gregianin L, Jaeger M, Nör C et al. Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma. Neuro-Oncology. 2022 Jul 31;24(7): 1210–1211. Epub 2022 May 11. doi: 10.1093/neuonc/noac061

Author

Roesler, Rafael ; de Farias, Caroline Brunetto ; Brunetto, André T et al. / Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma. In: Neuro-Oncology. 2022 ; Vol. 24, No. 7. pp. 1210–1211.

Bibtex

@article{9c2f16eb16df46ec93d1b8d7da077e42,
title = "Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma",
keywords = "Cancer Research, Neurology (clinical), Oncology",
author = "Rafael Roesler and {de Farias}, {Caroline Brunetto} and Brunetto, {Andr{\'e} T} and Lauro Gregianin and Mariane Jaeger and Carolina N{\"o}r and Amanda Thomaz",
note = "This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Neuro-Oncology following peer review. The definitive publisher-authenticated version Rafael Roesler, Caroline Brunetto de Farias, Andr{\'e} T Brunetto, Lauro Gregianin, Mariane Jaeger, Carolina N{\"o}r, Amanda Thomaz, Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma, Neuro-Oncology, 2022 24: 1210-1211, is available online at https://doi.org/10.1093/neuonc/noac061",
year = "2022",
month = jul,
day = "31",
doi = "10.1093/neuonc/noac061",
language = "English",
volume = "24",
pages = " 1210–1211",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press (OUP)",
number = "7",

}

RIS

TY - JOUR

T1 - Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma

AU - Roesler, Rafael

AU - de Farias, Caroline Brunetto

AU - Brunetto, André T

AU - Gregianin, Lauro

AU - Jaeger, Mariane

AU - Nör, Carolina

AU - Thomaz, Amanda

N1 - This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Neuro-Oncology following peer review. The definitive publisher-authenticated version Rafael Roesler, Caroline Brunetto de Farias, André T Brunetto, Lauro Gregianin, Mariane Jaeger, Carolina Nör, Amanda Thomaz, Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma, Neuro-Oncology, 2022 24: 1210-1211, is available online at https://doi.org/10.1093/neuonc/noac061

PY - 2022/7/31

Y1 - 2022/7/31

KW - Cancer Research

KW - Neurology (clinical)

KW - Oncology

U2 - 10.1093/neuonc/noac061

DO - 10.1093/neuonc/noac061

M3 - Journal article

VL - 24

SP - 1210

EP - 1211

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 7

ER -